Arriving in the landscape of obesity therapy, retatrutide is a distinct approach. Beyond many available medications, retatrutide functions as a double agonist, simultaneously targeting both GLP peptide-1 (GLP-1) and glucose-responsive insulinotropic substance (GIP) receptors. This simultaneous stimulation encourages several beneficial effects, incl